A Phase I Study to Evaluate the Safety and Tolerability of JL15003 Injection in Patients With Recurrent Glioblastoma
Clinical trial NCT07497373 · COMPLETED
Trial details
- NCT number
- NCT07497373
- Sponsor
- Jecho Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-16
- Primary completion
- 2024-05-23
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.